Open Access

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib

Ana Ursula Gavric

Ana Ursula Gavric

Eye Hospital, University Medical Centre LjubljanaLjubljana, Slovenia
Search for this author on
Sciendo|Google Scholar
Gavric, Ana Ursula
, 
Janja Ocvirk

Janja Ocvirk

  • Department of Medical Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
  • Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Search for this author on
Sciendo|Google Scholar
Ocvirk, Janja
 and 
Polona Jaki Mekjavic

Polona Jaki Mekjavic

  • Eye Hospital, University Medical Centre LjubljanaLjubljana, Slovenia
  • Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Search for this author on
Sciendo|Google Scholar
Mekjavic, Polona Jaki
  
Jan 24, 2018
Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib's Cover Image
About this article
Previous Article
Next Article
Cite
Download Cover
Article Category: Research Article
Published Online: Jan 24, 2018
Page range: 213 - 219
Received: Oct 04, 2017
Accepted: Nov 20, 2017
DOI: https://doi.org/10.2478/raon-2018-0002
Keywords
© 2018 Ana Ursula Gavric, Janja Ocvirk, Polona Jaki Mekjavic, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, Internal Medicine, Haematology, Oncology, Radiology
Journal RSS Feed